RU
Address
220006, Minsk, Leningradskaya Str. 6, office 2
Tel.: +375 17 363-88-92
E-mail: medjournal@bsmu.by

Роль хемокинов в патогенезе хронической обструктивной болезни легких

А.Г. Кадушкин, А.Д. Таганович УО «Белорусский государственный медицинский университет»
2012 №2 | В помощь практикующему врачу
Аннотация
Список литературы
Скачать полнотекстовую статью
Хроническая обструктивная болезнь легких (ХОБЛ) относится к актуальным проблемам современного общества. Вместе с сахарным диабетом, артериальной гипертензией и ишемической болезнью сердца, ХОБЛ составляет группу ведущих хронических заболеваний. Она занимает четвертое место в структуре смертности.
Ключевые слова:
хроническая обструктивная болезнь легких, хемокины
Role of chemokines in the pathogenesis of chronic obstructive pulmonary disease

Chronic obstructive pulmonary disease (COPD) refers to the actual problems of modern society. Together with diabetes, hypertension and coronary heart disease, COPD is a group of leading chronic diseases. It ranks fourth in the structure of mortality.

Keywords
chronic obstructive pulmonary disease, chemokines
  • 1. Actions of the chemotactic cytokines MCP-1, MCP-2, MCP-3, RANTES, MIP-1 alpha and MIP-1 beta on human monocytes / M. Uguccioni [et al.] // Eur. J. Immunol. 1995. Vol. 25. № 1. P. 64 – 68.
  • 2. A disintegrin and metalloproteinase 10-mediated cleavage and shedding regulates the cell surface expression of CXC chemokine ligand 16 / P.J. Gough [et al.] // J. Immunol. 2004. Vol. 172. № 6. P. 3678 – 3685.
  • 3. Autoantibodies in patients with chronic obstructive pulmonary disease / C.A. Feghali-Bostwick [et al.] // Am. J. Respir. Crit. Care Med. 2008. Vol. 177. № 2. P. 156 – 163.
  • 4. Baggiolini, M. Chemokines in pathology and medicine / M. Baggiolini // J. Intern. Med. 2001. Vol. 250. № 2. P. 91 – 104.
  • 5. Baggiolini, M. Interleukin-8 and related chemotactic cytokines — CXC and CC chemokines / M. Baggiolini, B. Dewald, B. Moser // Adv. Immunol. 1994. Vol. 55. P. 97 – 179.
  • 6. Bonzo/CXCR6 expression defines type 1-polarized T-cell subsets with extralymphoid tissue homing potential / C.H. Kim [et al.] // J. Clin. Invest. 2001. Vol. 107. № 5. P. 595 – 601.
  • 7. CCR3 functional responses are regulated by both CXCR3 and its ligands CXCL9, CXCL10 and CXCL11 / G. Xanthou [et al.] // Eur. J. Immunol. 2003. Vol. 33. № 8. P. 2241 – 2250.
  • 8. CD8 chemokine receptors in chronic obstructive pulmonary disease / L.J.C. Smyth [et al.] // Clin. Exp. Immunol. 2008. Vol. 154. № 1. P. 56 – 63.
  • 9. Cell surface!anchored SR!PSOX/CXC chemokine ligand 16 mediates firm adhesion of CXC chemokine receptor 6!expressing cells / T. Shimaoka [et al.] / / J. Leukoc. Biol. 2004. Vol. 75. № 2. P. 267 – 274.
  • 10. Chandrasekar, B. CXCL16 signals via Gi, phosphatidylinositol 3-kinase, Akt, I kappa B kinase, and nuclear factor-kappa B and induces cell-cell adhesion and aortic smooth muscle cell proliferation / B. Chandrasekar, S. Bysani, S. Mummidi // J. Biol. Chem. 2004. Vol. 279. № 5. P. 3188 – 3196.
  • 11. Chemokine expression by small sputum macrophages in COPD / M. Frankenberger [et al.] // Mol. Med. 2011. Vol. 17. № 7 – 8. P. 762 – 770.
  • 12. Chemokines generally exhibit scavenger receptor activity through their receptor-binding domain / T. Shimaoka [et al.] // J. Biol. Chem. 2004. Vol. 279. № 26. P. 26807 – 26810.
  • 13. Chemotactic mediators of Th1 T-cell trafficking in smokers and COPD patients / S. Brozyna [et al.] // COPD. 2009. Vol. 6. № 1. P. 4 – 16.
  • 14. Computed tomographic scan – diagnosed COPD – emphysema: CCL11 1 is associated with bronchodilator response and extent of emphysema / M. Miller [et al.] // J. Allergy Clin. Immunol. 2007. Vol. 120. № 5. P. 1118 – 1125.
  • 15. COPD association and repeatability of blood biomarkers in the ECLIPSE cohort / J. A. Dickens [et al.] // Respir. Res. 2011. Vol. 12. P. 1 – 10.
  • 16. Correlation between serum biomarkers and BODE index in patients with stable COPD / S.F. Liu [et al.] // Respirology. 2009. Vol. 14. № 7. P. 999 –1004.
  • 17. Cosio, M.G. Morphologic and morphometric effects of prolonged cigarette smoking on the small airways / M.G. Cosio [et al.] // Am. Rev. Respir. Dis. 1980. Vol. 122. № 2. P. 265 – 271.
  • 18. CXCR3 and CCR5 chemokines in induced sputum from patients with COPD / C. Costa [et al.] // Chest. 2008. Vol. 133. № 1. P. 26 – 33.
  • 19. Differences in interleukin-8 and tumor necrosis factor-alpha in induced sputum from patients with chronic obstructive pulmonary disease or asthma / V.M. Keatings [et al.] // Am. J. Respir. Crit. Care Med. 1996. Vol. 153. № 2. P. 530 – 534.
  • 20. Eotaxin-3/CCL26 is a natural antagonist for CC chemokine receptors 1 and 5. A human chemokine with a regulatory role / V. Petkovic [et al.] // J. Biol. Chem. 2004. Vol. 279. № 22. P. 23357 – 23363.
  • 21. Eotaxin is a natural antagonist for CCR2 and an agonist for CCR5 / P. Ogilvie [et al.] // Blood. 2001. Vol. 97. № 7. P. 1920 – 1924.
  • 22. Eotaxin-3 is a natural antagonist for CCR2 and exerts a repulsive effect on human monocytes / P. Ogilvie [et al.] // Blood. 2003. Vol. 102. № 3. P. 789 – 794.
  • 23. Expression and release of interleukin-8 by human bronchial epithelial cells from patients with chronic obstructive pulmonary disease, smokers, and never-smokers / C. Schultz [et al.] // Respiration. 2003. Vol. 70. P. 254 – 261.
  • 24. Freeman, С.M. CC Chemokine Receptor 5 and CXC Chemokine Receptor 6 Expression by Lung CD8 + Cells Correlates with Chronic Obstructive Pulmonary Disease Severity / С.M. Freeman, J.L. Curtis, S.W. Chensue //Am. J. Pathol. 2007. Vol. 171. № 3. P. 767 – 776.
  • 25. Geographic variations in prevalence and underdiagnosis of COPD: results of the IBERPOC multicentre epidemiological study / V.S. Pena [et al.] // Chest. 2000. Vol. 118. № 4. P. 981 – 989.
  • 26. Global burden of COPD: systematic review and meta!analysis / R.J. Halbert [et al.] // Eur. Respir. J. 2006. Vol. 28. № 3. P. 523 – 532.
  • 27. Hall, Z. Alveolar Macrophage Production of CXCR3 Chemokines / Z. Hall, P.J. Barnes, LE. Donnelly // Am. J. Respir. Crit. Care Med. 2004. A169.
  • 28. Hebert, C.A. Scanning mutagenesis of interleukin-8 identifies a cluster of residues required for receptor binding / C.A. Hebert, R.V. Vitangcol, J.B. Baker // J. Biol. Chem. 1991. Vol. 266. № 28. P. 18989 – 18994.
  • 29. Horuk, R. Chemokine receptors / R. Horuk // Cytokine Growth Factor Rev. 2001. Vol. 12. № 4. P. 313 – 335.
  • 30. Identification and characterization of an inhibitor of haemopoietic stem cell proliferation / G.J. Graham [et al.] // Nature. 1990. Vol. 344. P. 442 – 444.
  • 31. IL-18 together with anti-CD3 antibody induces human Th1 cells to produce Th1-and Th2-cytokines and IL-8 / H. Hata [et al.] // Int. Immunol. 2004. Vol. 16. № 12. P. 1733 – 1739.
  • 32. Increased levels of the chemokines GRO α and MCP-1 in sputum samples from patients with COPD / S.L. Traves [et al.] // Thorax. 2002. Vol. 57. №7. P. 590 – 595.
  • 33. Increased MCP-1 and MIP-1 β in bronchoalveolar lavage fluid of chronic bronchitis / A. Capelli [et al.] // Eur. Respir. J. 1999. Vol. 14. № 1. P. 160 – 165.
  • 34. Interferon gamma induction of pulmonary emphysema in the adult murine lung / Z. Wang [et al.] // J. Exp. Med. 2000. Vol. 192. № 11. P. 1587 – 1600.
  • 35. Interferon-inducible T cell alpha chemoattractant (I-TAC): a novel non- ELR CXC chemokine with potent activity on activated T cells through selective high affinity binding to CXCR3 / K.E. Cole [et al.] // J. Exp. Med. 1998. Vol. 187. № 12. P. 2009 – 2021.
  • 36. International Union of Pharmacology. XXII. Nomenclature for chemokine receptors / P.M. Murphy [et al.] // Pharmacol. Rev. 2000. Vol. 52. № 1. P. 145 – 176.
  • 37. ITAC/ CXCL11 is a natural antagonist for CCR5 / V. Petkovic [et al.] // J. Leukoc. Biol. 2004. Vol. 76. P. 701 – 708.
  • 38. Kim, C.H. Chemokines: signal lamps for traf?cking of T and B cells for development and effector function / C.H. Kim, H.E. Broxmeyer // J. Leukoc. Biol. 1999. Vol. 65. № 1. P. 6 – 15.
  • 39. Laudanna, C. Role of Rho in chemoattractant!activated leukocyte adhe sion through integrins / C. Laudanna, J.J. Campbell, E.C. Butcher // Science. 1996. Vol. 271. № 5251. P. 981 – 983.
  • 40. Lloyd, C. Chemokines in allergic lung inflammation / C. Lloyd // Immunology. 2002. Vol. 105. № 2. P. 144 – 154.
  • 41. Loetscher, P. Agonistic and antagonistic activities of chemokines / P. Loetscher, I. Clark!Lewis // J. Leukoc. Biol. 2001. Vol. 69. № 6. P. 881 – 884.
  • 42. Luster, A. D. Chemokines – chemotactic cytokines that mediate inflammation / A.D. Luster // N. Engl. J. Med. 1998. Vol. 338. № 7. P. 436 – 445.
  • 43. Monocyte chemoattractant protein-1 (MCP-1): an overview / S.L. Deshmane [et al.] // J. Interferon Cytokine Res. 2009. Vol. 29. № 6. P. 313 – 326.
  • 44. Multi analyte profiling and variability of inflammatory markers in blood and induced sputum in patients with stable COPD / S.D. Aaron [et al.] // Respir. Res. 2010. Vol. 11. № 41. P. 1 – 12.
  • 45. Murphy, P. M. Neutrophil receptors for interleukin!8 and related CXC chemokines / P.M. Murphy // Semin. Hematol. 1997. Vol. 34. № 4. P. 311 – 318.
  • 46. Platelet-derived CXC chemokines: old players in new games / E. Brandt [et al.] // Immunol. Rev. 2000. Vol. 177. P. 204 – 216.
  • 47. Quint, J. K. Serum IP-10 as biomarker of human rhinivirus infection at exacerbation of COPD / J.K. Quint // Chest. 2010. Vol. 137. № 4. P. 812 – 822.
  • 48. Recombinant human growth-regulated oncogene-alpha induces T lymphocyte chemotaxis. A process regulated via IL-8 receptors by IF Ngamma, TNF -alpha, IL-4, IL-10, and IL-13 / T. J. Jinquan [et al.] // Immunol. 1995. 155. №11. P. 5359 – 5368.
  • 49. Regulation of TNF- α and IFN- γ induced CXCL10 expression: participation of the airway smooth muscle in the pulmonary inflammatory response in chronic obstructive pulmonary disease / E. L. Hardaker [et al.] // FASEB J. 2004. Vol. 18. № 1. P. 191 – 193.
  • 50. Role of C-X-C chemokines as regulators of angiogenesis in lung cancer / R.M. Strieter [et al.] // J. Leukoc. Biol. 1995. Vol. 57. P. 752 – 762.
  • 51. Rollins, B. J. Chemokines / B.J. Rollins // Blood. 1997. Vol. 90. № 3. P. 909 – 928.
  • 52. Rossi, G. A. COPD patients or «healthy smokers»: is IL-8 synthesis and release the borderline? / G. A. Rossi // Respiration. 2003. Vol. 70. № 5. P. 457 – 459.
  • 53. Smoking status and tumor necrosis factor-alpha mediated systemic in flammation in COPD patients / S. E. Tanni [et al.] // J. Inflamm. 2010. Vol. № 7. P. 1 – 7.
  • 54. Specific CXC but not CC chemokines cause elevated monocyte migration in COPD: a role for CXCR2 / S. L. Traves [et al.] // J. Leukoc. Biol. 2004. Vol. 76. № 2. P. 441 – 450.
  • 55. Springer, T. A. Traffic signals for lymphocyte recirculation and leukocyte emigration: the multistep paradigm / T. A. Springer // Cell. 1994. Vol. 76. № 2. P. 301 – 314.
  • 56. Stanford, M. M. The relative activity of CXCR3 and CCR5 ligands in T lymphocyte migration: concordant and disparate activities in vitro and in vivo / M. M. Stanford, T. B. Issekutz // J. Leukoc. Biol. 2003. Vol. 74. № 5. P. 791 – 799.
  • 57. Structure activity relationships of interleukin-8 determined using chemically synthesized analogs. Critical role of NH2-terminal residues and evidence for uncoupling of neutrophil chemotaxis, exocytosis, and receptor binding activities / I. Clark-Lewis [et al.] // J. Biol. Chem. 1991. Vol. 266. № 34. P. 23128 – 23134.
  • 58. Systemic inflammatory markers in COPD: results from the Bergen COPD Cohort Study / T.M.L. Eagan [et al.] // Eur. Respir. J. 2010. Vol. 35. № 3. P. 540 – 548.
  • 59. The CXC-chemokine neutrophil-activating peptide-2 induces two distinct optima of neutrophil chemotaxis by differential interaction with interleukin-8 receptors CXCR-1 and CXCR-2 / A. Ludwig [et al.] // Blood. 1997. Vol. 90. № 11. P. 4588 – 4597.
  • 60. The interleukin-8-related chemotactic cytokines GRO alpha, GRO beta, and GRO gamma activate human neutrophil and basophil leukocytes / T. Geiser [et al.] // J. Biol. Chem. 1993. Vol. 268. № 21. P. 15419 – 15424.
  • 61. The selectins: vascular adhesion molecules / T. F. Tedder [et al.] // FASEB J. 1995. Vol. 9. №10. P. 866 – 873.
  • 62. Walz, A. Generation and properties of neutrophil-activating peptide 2 / A. Walz // Cytokines. 1992. Vol. 4. P. 77 – 95.
  • 63. Whittemore, A. S. Chronic obstructive pulmonary disease in lifelong nonsmokers: results from NHANES / A. S. Whittemore, S. A. Perlin, Y. DiCiccio // Am. J. Public Health. 1995. Vol. 85. № 5. P. 702 – 706.